The post Figure (FIGR) Has 40% Upside: Bernstein appeared on BitcoinEthereumNews.com. Bernstein initiated coverage of Figure (FIGR) with an outperform rating and a $54 price target, calling it a leader in bringing blockchain to credit markets, the broker said in a Monday report. The stock was 2% higher in early trade, around $41.10. Bernstein said Figure is doing for lending what stablecoins did for payments, tokenizing traditional assets to make markets faster and more efficient. With roughly 75% of the $17 billion tokenized private credit market, Figure is the clear frontrunner, according to analysts led by Gautam Chhugani. Figure’s blockchain platform shifts lending from a balance-sheet-heavy model to a capital-light marketplace, giving investors direct access to consumer loans, the report noted. Bernstein estimated that the addressable market for credit tokenization exceeds $2 trillion, providing “tremendous growth headroom” as Figure expands beyond home equity lines into other loan products and even equities. The broker cited Figure’s experienced management team and wide distribution network, with 170 origination partners and over 15 private credit investors, as key strengths. Figure is already the top independent home equity line of credit (HLOC) lender in the U.S., originating about $5.1 billion in 2024, or roughly 3% of the market. Bernstein expects revenue to rise from $341 million in 2024 to $754 million by 2027, a 30% annual growth rate, driven by Figure’s Connect marketplace. At about 19x EV/2027 EBITDA and 30x P/E, Figure trades at a premium, but Bernstein said its market dominance, profitability, and exposure to the fast-growing tokenization trend justify the valuation. Figure went public last month. It priced its IPO at $25 per share, valuing the company at $787.5 million. Read more: Blockchain-Based Lender Figure Prices IPO at $25 Per Share, Raising Nearly $788M Source: https://www.coindesk.com/markets/2025/10/06/figure-is-a-blockchain-pioneer-in-credit-markets-says-bernstein-initiating-at-outperformThe post Figure (FIGR) Has 40% Upside: Bernstein appeared on BitcoinEthereumNews.com. Bernstein initiated coverage of Figure (FIGR) with an outperform rating and a $54 price target, calling it a leader in bringing blockchain to credit markets, the broker said in a Monday report. The stock was 2% higher in early trade, around $41.10. Bernstein said Figure is doing for lending what stablecoins did for payments, tokenizing traditional assets to make markets faster and more efficient. With roughly 75% of the $17 billion tokenized private credit market, Figure is the clear frontrunner, according to analysts led by Gautam Chhugani. Figure’s blockchain platform shifts lending from a balance-sheet-heavy model to a capital-light marketplace, giving investors direct access to consumer loans, the report noted. Bernstein estimated that the addressable market for credit tokenization exceeds $2 trillion, providing “tremendous growth headroom” as Figure expands beyond home equity lines into other loan products and even equities. The broker cited Figure’s experienced management team and wide distribution network, with 170 origination partners and over 15 private credit investors, as key strengths. Figure is already the top independent home equity line of credit (HLOC) lender in the U.S., originating about $5.1 billion in 2024, or roughly 3% of the market. Bernstein expects revenue to rise from $341 million in 2024 to $754 million by 2027, a 30% annual growth rate, driven by Figure’s Connect marketplace. At about 19x EV/2027 EBITDA and 30x P/E, Figure trades at a premium, but Bernstein said its market dominance, profitability, and exposure to the fast-growing tokenization trend justify the valuation. Figure went public last month. It priced its IPO at $25 per share, valuing the company at $787.5 million. Read more: Blockchain-Based Lender Figure Prices IPO at $25 Per Share, Raising Nearly $788M Source: https://www.coindesk.com/markets/2025/10/06/figure-is-a-blockchain-pioneer-in-credit-markets-says-bernstein-initiating-at-outperform

Figure (FIGR) Has 40% Upside: Bernstein

Bernstein initiated coverage of Figure (FIGR) with an outperform rating and a $54 price target, calling it a leader in bringing blockchain to credit markets, the broker said in a Monday report.

The stock was 2% higher in early trade, around $41.10.

Bernstein said Figure is doing for lending what stablecoins did for payments, tokenizing traditional assets to make markets faster and more efficient.

With roughly 75% of the $17 billion tokenized private credit market, Figure is the clear frontrunner, according to analysts led by Gautam Chhugani.

Figure’s blockchain platform shifts lending from a balance-sheet-heavy model to a capital-light marketplace, giving investors direct access to consumer loans, the report noted.

Bernstein estimated that the addressable market for credit tokenization exceeds $2 trillion, providing “tremendous growth headroom” as Figure expands beyond home equity lines into other loan products and even equities.

The broker cited Figure’s experienced management team and wide distribution network, with 170 origination partners and over 15 private credit investors, as key strengths. Figure is already the top independent home equity line of credit (HLOC) lender in the U.S., originating about $5.1 billion in 2024, or roughly 3% of the market.

Bernstein expects revenue to rise from $341 million in 2024 to $754 million by 2027, a 30% annual growth rate, driven by Figure’s Connect marketplace. At about 19x EV/2027 EBITDA and 30x P/E, Figure trades at a premium, but Bernstein said its market dominance, profitability, and exposure to the fast-growing tokenization trend justify the valuation.

Figure went public last month. It priced its IPO at $25 per share, valuing the company at $787.5 million.

Read more: Blockchain-Based Lender Figure Prices IPO at $25 Per Share, Raising Nearly $788M

Source: https://www.coindesk.com/markets/2025/10/06/figure-is-a-blockchain-pioneer-in-credit-markets-says-bernstein-initiating-at-outperform

Market Opportunity
Polytrade Logo
Polytrade Price(TRADE)
$0.03269
$0.03269$0.03269
-0.33%
USD
Polytrade (TRADE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26